All lobbying filings

Avenue Solutions

Avenue Solutions filed a Q1 report for Genentech USA, Inc. on April 21, 2025, reporting $50,000 in lobbying income.

Lobbying for Genentech USA, Inc. · Biotechnology

As filed: AVENUE SOLUTIONS for GENENTECH USA, INC.

All filings by Avenue Solutions · Everything Genentech USA, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

MATTHEW FUENTES New on this filing

Previously held: LA - Senate Democratic Minority Leader Sen. Chuck Schumer; LA -Senate Democratic Majority Leader Sen. Chuck Schumer; Legislative Aide - Sen. Chuck Schumer; Research Assistant - Senate Finance Committee (Sen. Ron Wyden)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to healthcare access, quality and costs; Issues related to Medicare and Medicaid coverage and reimbursement; Medicare reimbursement for biosimilars

Health Issues

Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 340b drug pricing program; S. 891, Bipartisan Health Care Act H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

Bills named in this filing 2

S. 891
Bipartisan Health Care Act
H.R. 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.